Status:

UNKNOWN

Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome (pSS)

Lead Sponsor:

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Conditions:

Sjogren's Syndrome

Mesenchymal Stem Cells

Eligibility:

All Genders

15-70 years

Phase:

PHASE1

PHASE2

Brief Summary

This study will explore safety and efficacy of allogeneic mesenchymal stem cells transplantation (MSCT) to treat patients with diagnosis of primary Sjögren's Syndrome (pSS) who have been resistant to ...

Detailed Description

* To test a new approach using allogeneic derived mesenchymal stem cell based therapy (MSCT) to treat refractory primary Sjögren's Syndrome (pSS) * To determine the disease-free survival in pSS patien...

Eligibility Criteria

Inclusion

  • All patients fulfilled the international classification criteria (2002) for primary Sjögren's Syndrome, man or woman aged from 15 to 70 years old, Sjögren's Syndrome Disease Activity Index (SSDAI)≥8.
  • Stimulated whole saliva flow rate less than 1\~6ml/6min.
  • Patients must be informed of the investigational nature of this study and give written informed consent in accordance with the institutional and hospital guidelines.
  • Women of reproductive potential may not participate unless they have agreed to use an effective contraceptive method while on this trial and for 12 months following treatment. Women of child-bearing potential must have a pregnancy test performed within 72 hours prior to initiation of treatment.

Exclusion

  • End-stage renal failure.
  • Severe cardiopulmonary compromise, or other system failure.
  • Active, uncontrolled infections.
  • Pregnant or nursing women may not participate due to the possibility of fetal harm or harm to nursing infants from this treatment regimen.

Key Trial Info

Start Date :

June 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2011

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT00953485

Start Date

June 1 2009

End Date

December 1 2011

Last Update

August 20 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

the Affiliated Drum Tower Hospital of Nanjing University Medical School

Nanjing, Jiangsu, China, 210008

Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome (pSS) | DecenTrialz